Ameritas Investment Partners, Inc. - SUTRO BIOPHARMA INC ownership

Back to all holdings Add to watchlist

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$17,235
-25.4%
4,9670.0%0.00%0.0%
Q2 2023$23,097
+47.0%
4,967
+46.1%
0.00%0.0%
Q1 2023$15,708
-38.7%
3,4000.0%0.00%0.0%
Q4 2022$25,636
+42.4%
3,4000.0%0.00%0.0%
Q3 2022$18,000
+5.9%
3,4000.0%0.00%0.0%
Q2 2022$17,000
-39.3%
3,4000.0%0.00%0.0%
Q1 2022$28,000
-45.1%
3,4000.0%0.00%
-50.0%
Q4 2021$51,000
-20.3%
3,4000.0%0.00%0.0%
Q3 2021$64,000
+1.6%
3,4000.0%0.00%0.0%
Q2 2021$63,000
+5.0%
3,400
+28.6%
0.00%0.0%
Q1 2021$60,000
+25.0%
2,644
+19.0%
0.00%0.0%
Q4 2020$48,000
+118.2%
2,2220.0%0.00%
+100.0%
Q3 2020$22,000
+83.3%
2,222
+49.9%
0.00%0.0%
Q2 2020$12,000
+140.0%
1,482
+182.3%
0.00%–
Q1 2020$5,000
-16.7%
5250.0%0.00%–
Q4 2019$6,000
+20.0%
5250.0%0.00%–
Q3 2019$5,000
-16.7%
5250.0%0.00%–
Q2 2019$6,0000.0%5250.0%0.00%–
Q1 2019$6,000
+20.0%
5250.0%0.00%–
Q4 2018$5,000–525–0.00%–
 Download
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders